The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets.
about
MicroRNA Regulation of Human Breast Cancer Stem CellsIs Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshopTargeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem CellsLin28 sustains early renal progenitors and induces Wilms tumorWilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk.Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program.SIX2 Effects on Wilms Tumor Biology.Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumourThe yin and yang of kidney development and Wilms' tumorsDissecting Stages of Human Kidney Development and Tumorigenesis with Surface Markers Affords Simple Prospective Purification of Nephron Stem CellsIsolation and characterization of renal cancer stem cells from patient-derived xenograftsIdentification of human nephron progenitors capable of generation of kidney structures and functional repair of chronic renal disease.CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus.PPARG is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic targetTargeted therapy aimed at cancer stem cells: Wilms' tumor as an example.Renal progenitors and childhood: from development to disorders.The use of lineage tracing to study kidney injury and regeneration.Role of CD56 in Normal Kidney Development and Wilms Tumorigenesis.LINking microRNAs, kidney development, and Wilms tumorsEvidence of In Vitro Preservation of Human Nephrogenesis at the Single-Cell Level.The stem and roots of Wilms' tumours.Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors.The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour.The Ever-Expanding Kidney Repair Shop.A brief review of single-cell transcriptomic technologies.In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example
P2860
Q26771792-9E4B6A12-7ACD-4CA8-82F7-62190ECD4896Q26829595-89762578-55C6-4684-A0D8-62029C350405Q28078154-7E364F97-4D9B-4608-AB19-E5488D7C3079Q28511047-66431184-8DD8-4B6C-8317-B3A9EA4A3860Q33949184-48B8CDD9-A927-46B4-93B5-77DE634D9911Q34660299-59095F16-9B46-4A03-9CA4-1A1C92BC3568Q35028775-42703CBC-2170-4C15-AB8D-6321D253A362Q35163343-B0547683-C884-4420-BFDF-C6F7322AA31BQ35173260-6207B4BC-DF1C-43AA-BC22-3CD575AB4CEEQ36735915-F25BE4B6-7CBF-4D15-8021-B739BB33F4E7Q37085808-AA4C600B-3F9A-4A62-92FC-8155C3816D52Q37237128-AD454ACC-72A7-4088-8690-8A4C5EDF16CCQ37660299-7D144841-EB91-4032-966E-DD51208A5B57Q37734001-1DCAF921-AF6E-4915-B649-7535DA1AF589Q38114000-1705C867-CB17-4DB2-9859-097010C3C16BQ38175781-C5FE74BF-8CC3-4386-BA97-F93B56E5950FQ38473925-55D36C04-111F-4948-B16F-E06C7F786571Q39034075-CC10237E-1D80-45EC-B8F2-BED70DA95C43Q39526191-3D7657C3-172E-4A3D-9DA8-4B343A7F6807Q41018789-38BA36D3-D6D3-4FAE-BE1F-12E78AD3D58FQ41783611-B1EABDEE-8D60-4623-832F-9583BB1F607CQ42274969-2E1690A9-1684-4A0A-A324-4BEFD27DD2FBQ42685351-228D4F49-7122-4B36-A59E-54D0A55987F7Q42754552-96EAF280-5720-4439-8BFE-AC89CD519710Q47884138-D662835D-4AB2-4AE0-81A5-41FA34D850FCQ58772664-6B671F33-DA99-4EF5-A616-11D79907960D
P2860
The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The isolation and characteriza ...... veils new therapeutic targets.
@ast
The isolation and characteriza ...... veils new therapeutic targets.
@en
type
label
The isolation and characteriza ...... veils new therapeutic targets.
@ast
The isolation and characteriza ...... veils new therapeutic targets.
@en
prefLabel
The isolation and characteriza ...... veils new therapeutic targets.
@ast
The isolation and characteriza ...... veils new therapeutic targets.
@en
P2093
P2860
P356
P1476
The isolation and characteriza ...... veils new therapeutic targets.
@en
P2093
Amos Simon
Benjamin Dekel
Edward Fridman
Eithan Rom-Gross
Karen Meir
Marcus Magister
Michal Mark-Danieli
Naomi Pode-Shakked
Orit Harari-Steinberg
Peter Tsvetkov
P2860
P356
10.1002/EMMM.201201516
P577
2012-12-13T00:00:00Z